Newsletters

Download the newest CORRONA newsletters in PDF format below:

 CORRONA December 2011 Newsletter

  

Recent Publications

Peer Reviewed Publications and Manuscripts

The following list contains manuscripts published or awaiting publication (in press).

Anandarajah AP, El-Taha M, Peng C, Reed G, Greenberg JD and Ritchlin CT. The association between focal erosions and generalized bone loss in psoriatic arthritis. Ann Rheum Dis.2011 Jul;70(7):1345-7. Epub 2011 Feb 16.

Au K, Reed GW, Curtis JR, Kremer JM, Greenberg JD, Strand V, Furst DE. The Rate of Infections Is Increased As Disease Activity Increases in Rheumatoid Arthritis (RA). Ann Rheum Dis. 2011 May;70(5):785-791. Epub 2011 Feb 2.

Greenberg JD, Kremer JM, Curtis JR, Hochberg MC, Reed GW, Tsao P, Farkouh ME, Nasir A, Setoguchi S, Solomon DH. TNF antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann Rheum Dis. 2011 Apr;70(4):576-582. Epub 2010 Nov 24.

Reddy S, Anandarajah A, Fisher M, Mease P, Greenberg J, Kremer J, Reed G, Chen R, Messing S, Kaukeinen K, Ritchlin C. Comparative Analysis of Disease Activity Measures, Use of Biologic Agents, BMI, Radiographic Features, and Bone Density in Psoriatic Arthritis and Rheumatoid Arthritis Patients Followed in a Large US Disease Registry.The Journal of Rheumatology.2010 Dec; 37(12): 2566-72. Published Online First. 2010 September 15.

Solomon DH, Kremer JM, Curtis JR, Hochberg M, Reed G, Tsao P, Farkouh M, Setoguch S, and Greenberg JD. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional rsk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis. 2010;69:1920–1925.

Sokolove J, Strand V, Greenberg JD, Curtis JR, Kavanaugh A, Kremer JM, Anofrei A, Reed R, Calabrese L, Hooper M, Baumgertner S, and Furst D. Risk of elevated liver enzymes associated with TNF inhibitor utilization in patients with rheumatoid arthritis. Ann Rheum Dis. 2010 Sep; 69(9): 1612-7.

Bentley MJ, Greenberg JD, Reed GW. A modified rheumatoid arthritis disease activity score without acute-phase reactants (mDAS28) for epidemiological research. J Rheumatology. 2010 Aug 1; 37(8): 1607-14.

Greenberg JD, Reed G, Kremer JM, Tindall E, Kavanaugh A, Zheng C, Bishai W, Hochberg M. Association of methotrexate and TNF antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry. Ann Rheum Dis. 2010 Feb; 69(2): 380-6.

Curtis JR, Chen L, Harrold LR, Narongroeknawin P, Reed G, Solomon DH. Physician preference motivates the use of anti-tumor necrosis factor therapy independent of clinical disease activity. Arthritis Care Res. 2010 Jan 15;62(1):101-7.

Curtis JR, Beukelman T, Onofrei A, Strand V, Greenberg JD, Reed G, Kremer JM. Elevated liver enzyme tests among rheumatoid arthritis or psoriatic arthritis patients treated with methotrexate and/or leflunomide. Annals of Rheumatic Disease 2010 Jan; 69(1):43-7.

Kremer JM, Greenberg JD. Interpreting registry derived drug studies: does societal context matter? Arthritis Rheum. 2009 Nov; 60(11):3155-7.

Curtis JR, Patkar NM, Jain A, Greenberg J, Solomon DH. The Validity of Physician-Reported Hospitalized Infections in An Observational U.S. Arthritis Registry. Rheumatology. 2009 Oct;48(10):1269-72.

Lee SJ, Chang H, Yazici Y, Greenberg JD, Kremer JM, Kavanaugh A. Utilization trends of tumor necrosis factor inhibitors among rheumatoid arthritis patients in a United States observational cohort study. J Rheumatol. 2009 Aug; 36(8):1611-7.

Furst D, Chang H, Greenberg J, Ranganath V, Reed G, Ozturk Z, Kremer JM. Prevalence of low hemoglobin levels and associations with other disease parameters in rheumatoid arthritis patients: Evidence from the CORRONA registry. Clin Exp Rheumatol. 2009 Jul-Aug;27(4): 560-6.

Greenberg JD, Harrold LR, Bentley MJ, Kremer J, Reed G. Strand V. Evaluation of composite measures of treatment response without acute phase reactants in patients with rheumatoid arthritis. Rheum Oxford. 2009 June;48(6):686-90

Coulson KA, Reed G, Gilliam BE, Kremer JM, Pepmueller PH. Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry. J Clin Rheumatol. 2009 Jun;15(4):155-60.

Greenberg JD, Fisher MC, Kremer J, Chang H, Rosenstein ED, Kishimoto M, Lee S, Yazici Y, Kavanaugh A Abramson SB. The COX-2 inhibitor market withdrawals and prescribing patterns by rheumatologists in patients with gastrointestinal and cardiovascular risk. Clinical and Experiminetal Rheumatology. 2009 May-Jun;27(3):395-401

Greenberg JD, Kishimoto M, Strand V, Cohen SB, Olenginski TP, Harrington JT, Kafka SP, Reed G, Kremer JM. TNF antagonist responsiveness in a United States rheumatoid arthritis cohort. Am J Med. 2008 June;121(6):532-538.

Ranganath VK, Paulus HE, Onofrei A, Khanna D, Reed G, Elashoff DA, Kremer JM, Furst DE.Functional improvement after patients with rheumatoid arthritis start a new disease modifying anti-rheumatic drug (DMARD) associated with frequent changes in DMARD: the CORRONA database. J Rheumatol. 2008 Oct;35(10):1966-71.

Published Abstract List

Nelson D, Sarsour K, Johnston J, Chen R, Messing S, Kaukeinen K, Tu X, Reed G, Greenberg JD. Biologic Disease-Modifying Anti-Rheumatic Drug Treatment Patterns and Associated Clinical Outcomes. Ann Rheum Dis 2010;69(Suppl3):680.

Cuyun Carter G, Sterling K, Messing S, Reed G, Chen R, Kaukeinen K. Baseline Predictors of Response to Anti-TNF Treatments. Ann Rheum Dis 2010;69(Suppl3):351.

Randall E, Harrold LR, Reed GW, Furst DE, Ruderman EM. Response to Adding a TNF Inhibitor (TNFI) to Methotrexate in Clinical Practice. Ann Rheum Dis 2010;69(Suppl3):674.

Kavanaugh A, Greenberg J, Lee S, Reed G, Kremer J, Onofrei A, Baumgartner S. Incidence of Elevated Liver Enzymes (LFTS) in Psoriatic Arthritis (PS) Patients: Effect of TNF=Inhibitors (TNF-I). Ann Rheum Dis 2010;69(Suppl3):579.

Harrold L, Reed G, Rosenblatt L, Moniz Reed D, Greenberg J. Comparative Effectiveness of Abatacept Versus Anti-TNF Agents in the Treatment of Biologic-Naïve Rheumatoid Arthritis Patients, Using the CORRONA Registry. Ann Rheum Dis 2010;69(Suppl3):478.

Solomon D, Hochberg M, Fisher M, Curtis J, Furer V, Harrold L, Reed G, Kremer J, Greenberg J. Malignancy Risk in a Very Large Cohort of Rheumatoid Arthritis. Ann Rheum Dis 2010;69(Suppl3):519

Gibofsky A, Kremer JM, Moniz Reed D, Reed G, Vratsanos G, Greenberg JD . Experience with abatacept in a US observational cohort: clinical and patient-reported outcomes from the CORRONA registry. Annals of the Rheumatic Diseases 2009;68(Suppl3):437.

Curtis JR, Patkar N, Jain A, Greenberg JD, Solomon DH. The validity of physician-reported hospitalized infections in a US rheumatoid arthritis cohort. Annals of the Rheumatic Diseases 2009;68(Suppl3):558.

Furst DE, Chang H, Khanna D, Reed G, Moniz Reed D, Rosenblatt LC, Mody M, Kremer JM, Greenberg JD. Rates of remission in RA depend on remission definition, duration of disease state, age and disease activity-associated factors. Annals of the Rheumatic Diseases 2009;68(Suppl3):224.

Furst DE, Greenberg JD, Reed G, Chang H, Pangan AL. Likelihood of clinical remission on anti-TNF therapy (TNFI). Annals of the Rheumatic Diseases 2009;68(Suppl3):234

Decktor DL, Harrold LR, Bolce R, Reed G, DeHoratius R, Greenberg JD. Patterns of drug use after initiation of anti-TNF rheumatoid arthritis. Annals of the Rheumatic Diseases 2009;68(Suppl3):235.

Setoguchi S, Greenberg JD, Curtis JR, Hochberg MC, Reed G Tsao P, Farkouh ME, Kremer JM, Solomon DH. Markers of disease severity predict new-onset heart failure in rheumatoid arthritis. Arthritis & Rheumatism 2009;60(S10):S1375.

Harrold LR, Greenberg JD, Curtis JR, Bentley MJ, Reed G, Harrington JT. Rheumatologists’ prescribing patterns for rheumatoid arthritis patients with active disease. Arthritis & Rheumatism 2009;60(S10):S1009.

Curtis JR, Chen L, Cush JL, Dao KH, Delzell E, Furst DE, Greenberg JD, Hochberg MC, Jain A, Kremer JM, Patkar N, Solomon DH. The risk for hospitalized and outpatient infections related to anti-TNF therapy and newer biologics. Arthritis & Rheumatism 2009;60(S10):S2059.

Lee SJ, Reed G, Kremer JM, Kavanaugh A. Characteristics of rheumatoid arthritis (RA) patients starting abatacept and rituximab. Arthritis & Rheumatism 2009;60(S10):S1610.

Ranganath VK, Maranian P, Hahn T, Elashoff D, Furst DE, Kremer JM, Paulus HE. Comorbidities correlates better than age with CDAI improvement in RA patients using the CORRONA Registry. Arthritis & Rheumatism 2009;60(S10):S972.

Finckh A, Scherrer A, Reed G, Greenberg JD, Lubbeke A, Schwarz H, C. Gabay C, Kremer JM. Obesity and RA disease severity: a comparison between European and American RA Patients. Arthritis & Rheumatism 2009;60(S10):S970.

Anandarajah AP, El-Taha M, Peng C, Greenberg JD, and Ritchlin C. The association between focal bone loss (erosions) and generalized bone loss (osteoporosis) in rheumatoid arthritis. Arthritis & Rheumatism 2009;60(S10):S373.

Gibofsky A, Kremer JM, Reed DM, Reed G, Klem C, Greenberg JD. Early experience with abatacept in a US observational cohort: clinical and patient report outcomes from the CORRONA registry. Arthritis & Rheumatism 2008;58(9):S309-S309.

Greenberg JD, Gibofsky A, Reed G, Decktor DL, Dehoratius R, Kremer JM. Effectiveness of TNF inhibitors (TNF-I) in biologic naive and switched RA patients in a US cohort. Arthritis & Rheumatism 2008;58(9):S524-S525.

Solomon DH, Curtis JR, Kremer JM, Reed G, Hochberg MA, Setoguchi S, et al. TNF blocker use and cardiovascular outcomes. Arthritis & Rheumatism 2008;58(9):S544-S544.

Sokolove J, Strand V, Greenberg JD, Curtis JR, Kavanaugh A, Kremer JM, et al. Risk of elevated liver enzymes (LFTS) with TNF inhibitors (TNF-I) in rheumatoid arthritis: Analysis in 6,861 patients with 22,552 visits. Arthritis & Rheumatism 2008;58(9):S779-S779.

Anandarajah AP, Greenberg JD, El-Taha M, Reed G, Peng C, Ritchlin CT. The relationship between erosions and osteoporosis in patients with psoriatic arthritis. Arthritis & Rheumatism 2008;58(9):S366-S367.

Fisher MC, El-Taha M, Kremer JM, Peng C, Greenberg JD. Smoking cessation and improvement of RA disease activity. Arthritis & Rheumatism 2008;58(9):S610-S610.

Furst DE, Chang H, Ranganath VK, Kremer JM, Reed G, Law A, et al. Increases in hemoglobin levels are associated with improved activities of daily living (mHAQ) in rheumatoid arthritis patients. Arthritis & Rheumatism 2008;58(9):S761-S762.

Solomon D, Greenberg JD, Reed G, Kishimoto M, Hinkle K, Abramson S, Kremer JM. Cardiovascular risk among patients with RA in CORRONA: comparing the explanatory value of traditional cardiovascular risk factors with RA. Annals of the Rheumatic Diseases 2008;67:482.

Gibofsky A, Greenberg JD, Reed GW, Decktor DL, DeHoratius R, Kremer JM. Persistancy, Response and Remission on the TNF Antagonnists in RA in a U.S. Cohort. Annals of the Rheumatic Diseases 2008;67:182.

Furst DE, Sokolove J, Greenberg JD, Curtis JR, Kavanaugh A, Kremer JM, Reed G, Calabrese L, Hooper M, Baumgartner S, Strand V. Risk of elevated liver enzymes (LFTS) with TNF inhibitors (TNF-I) in rheumatoid arthritis: Analysis in 6,861 patients with 22,552 visits. Annals of the Rheumatic Diseases 2008;67:52.

Anandarajah AP, Greenberg JD, El-Taha M, Peng C, Reed G, Ritchlin CT. The relationship between erosions and osteoporosis in patients with psoriatic arthritis. Arthritis & Rheumatism. Annals of the Rheumatic Diseases 2008;67:101.